KCT0003367
Completed
N/A
Effect of short-course radiotherapy followed by neoadjuvant Xelox (Capecitabine and Oxaliplatin) chemotherapy and total mesorectal excision in MRI defined high-risk rectal cancer: A phase II trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yonsei University Health System, Severance Hospital
- Enrollment
- 31
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. High\-risk patients of rectal cancer on pretreatment MRI using the following risk stratification system
- •? Location of the lower part of the tumor is measured below less than 10 cm on the anal verge and lower part of the tumor is located below the lower limit of the peritoneal reflection.
- •? If there is more than one, classify as a high risk group
- •? Positive CRM threatening:
- •? 5mm ? Extramural depth
- •? Positive EMVI.
- •? Positive Lateral pelvic LN metastasis
- •2\. Between 19 and 80 years of age;
- •3\. Satisfactory performance status: ECOG?2
- •4\. American Society of Anesthesiologists (ASA) physical status classification system class I\~III
Exclusion Criteria
- •1\. The evidenc of relapse of distant metastasis
- •2\. Receiving treatment of other anti\-cancer drug or methods
- •3\. Patients have low compliance and are not able to complete the entire trial
- •4\. Presence of uncontrolled life\-threatening diseases
- •5\. cT4 with infiltration of anterior organ on pretreatment MRI
- •6\. cT4 with infiltration of internal or external anal sphincter on pretreatment MRI
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patientsEUCTR2016-003468-38-FRCentre François baclesse
Completed
N/A
A Phase II Study of Short-course Radiotherapy Preoperatively followed by Capecitabine and Oxaliplatin (XELOX) for cT3 Node-positive Lower Rectal Cancerow rectal cancerJPRN-UMIN000023361Cancer Institute Hospital of Japanese Foundation for Cancer Research28
Recruiting
Phase 2
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel for inoperable or recurrent PD-L1 positive triple negative breast cancerinoperable or recurrent PD-L1 positive triple negative breast cancerJPRN-jRCTs021210010Suzuki Yoshiyuki20
Recruiting
N/A
Prospective observational study of radiotherapy with respiratory migration countermeasures for breast cancerJPRN-UMIN000045576Kagawa University Hospital30
Completed
N/A
Pre-operative short-course radiotherapy versus neoadjuvant radiochemotherapy in locally advanced rectal cancer (uT2N+, uT3N-/+)Rectal cancerCancerColorectal cancerISRCTN56463377Berlin Cancer Society (Berliner Krebsgesellschaft e.V.) (Germany)760